- Gilead, in latest cancer bet, puts $275M into immunotherapy startup Pionyr – BioPharma Dive
- Study shows new way of identifying tumor response to immunotherapy – Medical Xpress
- Vitamin D Could Help Prevent Common Side Effect of Anticancer Immunotherapy – Technology Networks
- A boost for cancer immunotherapy – MIT News
- Therapeutic Solutions to use immunotherapy for COVID-19 – The Science Board
- Transgene Presents Promising New Data from its Next-Generation Immunotherapy Platforms at AACR 2020 | DNA RNA and Cells | News Channels – PipelineReview.com
- Vitamin D may help prevent a common side effect of anti-cancer immunotherapy – EurekAlert
